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To the Editor:
As clinical investigators and scientists in the Y chromo-
some deletion field, we wish to express our concern about
the study by Feng et al. (1) that purports to show a signifi-
cantly increased risk of de novo Y chromosome deletions
in children conceived by assisted reproductive technology
(ART). We believe it has serious technical flaws and will
serve to confuse and concern the readership.
First, in terms of patient selection, it is remarkable that the
37 ART fathers had the same semen quality as the control
group with a mean sperm density of 91.5 million/mL. Such
an inclusion criterion is at variance with worldwide ART
practice and yet passes without comment.
Most critically, we question the performance of the Y dele-
tion analysis. Overdetection (false positives) is a major issue in
Y chromosome deletion studies, and for this reason there have
been significant international efforts to provide a quality insur-
ance program (2). Their brief method section suggests that the
authors have not participated in any quality control program.
These authors have published previously (3) a staggering
33% incidence of Y chromosome deletions in idiopathic non-
obstructive azoospermia. This is many fold higher than that
reported by others using appropriately stringent methods
for Yq deletion detection (4) and serves to raise questions
about the molecular methods used to define Yq deletions
and the overall validity of the data. Independent confirmation
of their data should have been sought.
We also note their claim that two of the four deletions were
limited to the AZFa region. The authors (and the referee) are
Fertility and Sterilityclearly not aware of the limits of the AZFa region because the
STS marker sY82 is erroneously indicated as being ‘‘in the
AZFa region.’’ Moreover, the four deletions found by the au-
thors were all single STS deletions, which require further
confirmation (at least with a few contiguous markers) given
that dealing with STS plus/minus analysis there is a high
probability of generating polymerase chain reaction (PCR)
artifacts. In addition, given that the RNA recognition motif
1 is present several times along the Y chromosome, the likeli-
hood of finding an isolated deletion for this specific marker is
negligible. The European Academy of Andrology (EAA)
Guidelines (2) for the valid detection of AZF deletions con-
tain all the relevant methodological and clinical information,
including the need for a reliable set of primers and the need
for confirmation of results.
Finally, the authors state that ‘‘[t]he incidence of microde-
letion was higher in children conceived via ICSI than in those
conceived by IVF (3:18 vs. 1:19),’’ and yet they go on to say
that this was not statistically significant. This reveals a lack of
statistical understanding and underscores the limited power
of this small study. Several of us were involved in a previous
study that looked in detail into this issue in a properly se-
lected group of 86 severely infertile men who were thus
candidates for intracytoplasmic sperm injection (ICSI), and
we found no evidence for de novo chromosome deletions in
their 99 ICSI-conceived male offspring (5).
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merase chain reaction (PCR) using the primers reported pre-
viously; we found a section of RNA recognition motif 1
(YRRM1) was deleted, but we did not mean that all the cop-
ies of YRRM1 were deleted. No Y chromosome microdele-
tion was found in naturally conceived offspring and their
fathers, indicating that the detected microdeletion in ART
offspring should not be a false-positive result. Of course, if
additional confirmation had been done, the results would be
more convincing.
No statistically significant difference was found in the inci-
dence of microdeletion between ICSI and IVF offspring. This
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The letter to the editor by Dr. McLachlan et al. expressed
their concern about our recent study (1), which showed a sig-
nificantly increased risk of de novo Y chromosome deletions
in children conceived by assisted reproductive technology
(ART). We appreciate the concern from these doctors and
others, and we would like to discuss our study with them.
The participants in our study were selected as follows.
Couples requesting ART treatment for tubal infertility in
our center in 2004 were informed about our research, and
nearly 200 couples consented to take part. They were ran-
domly divided into an in vitro fertilization (IVF) group and
an intracytoplasmic sperm injection (ICSI) group. Thirty-
seven male offspring conceived through ART constituted
the study group. So semen quality is not a routine inclusion
criterion for ICSI.
In our previously published study (2), Y-chromosome mi-
crodeletions were detected in 13.2% of patients with idiopathic
azoospermia. Among those patients, there were microdele-
tions in 33.3% of the men with high serum levels of follicle-
stimulating hormone (FSH). The generally accepted deletion
frequency for idiopathic severe oligospermic and azoospermic
men is 10% to 18%. We do not believe that the incidence we
found was higher than that found in other studies.
As we have successfully performed Y chromosome micro-
deletion detection in infertile men and quite a few published
papers have adopted similar methods, we used the same
method to investigate microdeletions in offspring. The quality
control program was as follows. A healthy man of proven
fertility and a healthy woman were included as positive and
negative controls, respectively, and were run in parallel with
each reaction. Patients were considered negative only after
three amplification failures. Because these details had been
described in our previous report (2), we omitted them from
the current report. The European Academy of Andrology
(EAA) Guidelines for the valid detection of AZF deletions
(3) have been recommended as being more stringent, so we
will employ those methods in our future studies.
Because SY82 locates at the proximal region of the AZFa
region and it is included in the AZFa region in some studies,
we described it in the AZFa region. We performed poly-
the presentation is not precise enough, but we were emphasiz-
ing the difference in incidence of microdeletion between ART
and naturally conceived offspring, which was statistically sig-
nificant. Cram et al. (4) found no de novo chromosome dele-
tions in 99 ICSI-conceived male offspring (4), but it has been
reported that ICSI may lead to vertical transmission, expan-
sion, and de novo Y-chromosome microdeletion (5). Our
study tries to show a potential risk that the incidence of micro-
deletion might increased in ART-conceived offspring. We will
enlarge the sample size and adopt more specific methods in
our subsequent studies to confirm our results.
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